Skip to Main Content

Paper Details

Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021.
JAMA Health Forum
3
2022
Author NameAffiliation
Nilay D Shah
Joseph S RossNational Clinician Scholars Program, Yale School of Medicine
Joseph S RossYale School of Medicine
Joseph S RossYale School of Public Health
Joseph S RossCenter for Outcomes Research and Evaluation, Yale New Haven Hospital
  • 1 - 5

Datasets

Release 1.2